Cargando…

Targeting Key Players of Neuroendocrine Differentiation in Prostate Cancer

Neuroendocrine prostate cancer (NEPC) is a highly aggressive subtype of prostate cancer (PC) that commonly emerges through a transdifferentiation process from prostate adenocarcinoma and evades conventional therapies. Extensive molecular research has revealed factors that drive lineage plasticity, u...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zamora, Irene, Freeman, Michael R., Encío, Ignacio J., Rotinen, Mirja
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10531052/ https://www.ncbi.nlm.nih.gov/pubmed/37761978 http://dx.doi.org/10.3390/ijms241813673

Ejemplares similares

ONECUT2 as a new therapeutic target in androgen receptor-indifferent prostate cancer
por: Freeman, Michael R., et al.
Publicado: (2019)

Changes in Gene Expression Profiling of Apoptotic Genes in Neuroblastoma Cell Lines upon Retinoic Acid Treatment
por: Celay, Jon, et al.
Publicado: (2013)

“Defining the Independence of the Liver Circadian Clock” & “BMAL1-Driven Tissue Clocks Respond Independently to Light to Maintain Homeostasis”
por: Rotinen, Mirja
Publicado: (2020)

From Prostate to Bone: Key Players in Prostate Cancer Bone Metastasis
por: Thobe, Megan N., et al.
Publicado: (2011)

Molecular mechanisms of neuroendocrine differentiation in prostate cancer progression
por: Xie, Yuchen, et al.
Publicado: (2022)

Role of key players in paradigm shifts of prostate cancer bone metastasis
por: Sohail, Ayesha, et al.
Publicado: (2018)

Target Heterogeneity in Oncology: The Best Predictor for Differential Response to Radioligand Therapy in Neuroendocrine Tumors and Prostate Cancer
por: Puranik, Ameya D, et al.
Publicado: (2021)

MicroRNAs in treatment-induced neuroendocrine differentiation in prostate cancer
por: Akoto, Theresa, et al.
Publicado: (2020)

Prostate cancer with neuroendocrine differentiation – case report
por: Glück, G, et al.
Publicado: (2012)

Myeloid-Derived Suppressor Cells as Key Players and Promising Therapy Targets in Prostate Cancer
por: Siemińska, Izabela, et al.
Publicado: (2022)

Neuroendocrine Differentiation of Prostate Cancer—An Intriguing Example of Tumor Evolution at Play
por: Patel, Girijesh Kumar, et al.
Publicado: (2019)

Regulation of Neuroendocrine-like Differentiation in Prostate Cancer by Non-Coding RNAs
por: Slabáková, Eva, et al.
Publicado: (2021)

Current advances of targeting epigenetic modifications in neuroendocrine prostate cancer
por: Cheng, Wen-Chi, et al.
Publicado: (2021)

Androgen-deprivation therapy-induced aggressive prostate cancer with neuroendocrine differentiation
por: Lipianskaya, Julia, et al.
Publicado: (2014)

Prognostic role of neuroendocrine differentiation in prostate cancer, putting together the pieces of the puzzle
por: Berruti, Alfredo, et al.
Publicado: (2010)

Neuroendocrine and Aggressive-Variant Prostate Cancer
por: Spetsieris, Nicholas, et al.
Publicado: (2020)

The Many Faces of Neuroendocrine Differentiation in Prostate Cancer Progression
por: Terry, Stéphane, et al.
Publicado: (2014)

SIRT1 contributes to neuroendocrine differentiation of prostate cancer
por: Ruan, Lin, et al.
Publicado: (2017)

FOXA1 inhibits prostate cancer neuroendocrine differentiation
por: Kim, Jung, et al.
Publicado: (2017)

Beta-adrenergic signaling on neuroendocrine differentiation, angiogenesis, and metastasis in prostate cancer progression
por: Zhao, Yicheng, et al.
Publicado: (2019)

SF-1 a key player in the development and differentiation of steroidogenic tissues
por: Val, Pierre, et al.
Publicado: (2003)

Does Valproic Acid Induce Neuroendocrine Differentiation in Prostate Cancer?
por: Sidana, Abhinav, et al.
Publicado: (2011)

Circular RNAs in cancer: an emerging key player
por: Dong, Yeping, et al.
Publicado: (2017)

Immunosenescence: a key player in cancer development
por: Lian, Jingyao, et al.
Publicado: (2020)

Autophagy: A Key Player in Pancreatic Cancer Progression and a Potential Drug Target
por: Gillson, Josef, et al.
Publicado: (2022)

Prostate tumor neuroendocrine differentiation via EMT: The road less traveled
por: Dicken, Haley, et al.
Publicado: (2019)

Role of MicroRNAs in Neuroendocrine Prostate Cancer
por: Sreekumar, Amritha, et al.
Publicado: (2022)

GRK3 is a direct target of CREB activation and regulates neuroendocrine differentiation of prostate cancer cells
por: Sang, Meixiang, et al.
Publicado: (2016)

Targeting Neuroendocrine Prostate Cancer: Molecular and Clinical Perspectives
por: Vlachostergios, Panagiotis J., et al.
Publicado: (2015)

Mesenchymal stem cells: key players in cancer progression
por: Ridge, Sarah M., et al.
Publicado: (2017)

Immuno-Metabolism and Microenvironment in Cancer: Key Players for Immunotherapy
por: Giannone, Gaia, et al.
Publicado: (2020)

Cancer Stem Cells—Key Players in Tumor Relapse
por: Marzagalli, Monica, et al.
Publicado: (2021)

FADD as a key molecular player in cancer progression
por: Liu, Ying, et al.
Publicado: (2022)

Prostate Cancer and Neuroendocrine Differentiation: More Neuronal, Less Endocrine?
por: Grigore, Alexandru Dan, et al.
Publicado: (2015)

Imaging Somatostatin Receptor Activity in Neuroendocrine-differentiated Prostate Cancer
por: Mori, Hiroshi, et al.
Publicado: (2018)

The Correlation between PSCA Expression and Neuroendocrine Differentiation in Prostate Cancer
por: Xiang, Qian, et al.
Publicado: (2020)

Is the glucocorticoid receptor a key player in prostate cancer?: A literature review
por: Sakellakis, Minas, et al.
Publicado: (2022)

Cancer-associated adipocytes: key players in breast cancer progression
por: Wu, Qi, et al.
Publicado: (2019)

Imaging of Neuroendocrine Prostatic Carcinoma
por: Taher, Ahmed, et al.
Publicado: (2021)

Dermatomyositis associated with prostate adenocarcinoma with neuroendocrine differentiation
por: Minagawa, Hideyuki, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8g1begil4latg9h1od11se9gmr